{"entity":{"id":"halmed-croatia","kind":"institution","name":"Agency for Medicinal Products and Medical Devices of Croatia","aka":["HALMED","Agencija za lijekove i medicinske proizvode"],"tldr":"Croatia's national medicines regulator. New cancer medicines reach Croatia mostly through the EU's centralised procedure; HALMED handles national authorisations and safety monitoring.","summary":"HALMED, the Agency for Medicinal Products and Medical Devices (Agencija za lijekove i medicinske proizvode), regulates medicines and medical devices in Croatia, including marketing authorisation, inspection and pharmacovigilance, as its page listing its activities says. As an EU member, Croatia receives medicines with a new active substance for cancer through the European Medicines Agency's centralised procedure, which the EMA says is compulsory for them and valid in every member state; whether the Croatian Health Insurance Fund pays for them is a separate national decision. The coordinates on this record are an approximate Zagreb point.","asOf":"2026-11-11","links":[{"label":"HALMED: about HALMED","url":"https://www.halmed.hr/O-HALMED-u/"},{"label":"HALMED: Djelatnosti (activities)","url":"https://www.halmed.hr/O-HALMED-u/Osnovni-podaci-i-dokumenti/Djelatnosti/"},{"label":"EMA: authorisation of medicines","url":"https://www.ema.europa.eu/en/about-us/what-we-do/authorisation-medicines"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["hzzo-croatia"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Zagreb","country":"HR","lat":45.8,"lng":15.97,"institutionType":"government","website":"https://www.halmed.hr","programs":["National authorisations","Pharmacovigilance","Inspection"]},"route":"/institutions/halmed-croatia/","neighbours":{"institution":[{"id":"hzzo-croatia","kind":"institution","name":"Croatian Health Insurance Fund","route":"/institutions/hzzo-croatia/"}]}}